Piperonyl butoxide mutagenicity in human RSa cells

Related Experiment Videos

H Suzuki1, N Suzuki

  • 1Department of Toxicology, Tokyo Metropolitan Research Laboratory of Public Health, Japan.

Mutation Research
|August 1, 1995
PubMed

Insights

Piperonyl butoxide (PB) causes mutagenicity in human cells, inducing specific gene mutations. This pesticide synergist demonstrated a dose-dependent effect on cell mutation frequency.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Genetics

Background:

  • Piperonyl butoxide (PB) is widely used as a pesticide synergist and food additive.
  • Understanding the genotoxic potential of PB is crucial for public health and safety.

Purpose of the Study:

  • To investigate the chemically induced mutagenicity of Piperonyl butoxide (PB) in cultured human cells.
  • To identify specific genetic alterations, including K-ras mutations, following PB exposure.

Main Methods:

  • Human RSa cells were exposed to varying concentrations of PB.
  • Ouabain-resistant (Ouar) phenotypic mutations were determined.
  • K-ras codon 12 mutations in genomic DNA were analyzed using polymerase chain reaction (PCR) and differential dot-blot hybridization.

Main Results:

  • PB induced mutagenicity in human RSa cells, with the highest mutation frequency observed at 0.2 microgram/ml.
  • K-ras codon 12 mutations were detected in RSa cells 6 days after exposure to PB concentrations ranging from 0.03 to 0.40 microgram/ml.
  • A dose-dependent relationship was observed for PB-induced mutations.

Conclusions:

  • Piperonyl butoxide exhibits mutagenic properties in human cells.
  • PB exposure can lead to specific genetic mutations, including K-ras mutations, highlighting potential genotoxic risks.
  • Further research is warranted to assess the long-term health implications of PB exposure.

Related Concept Videos